Abstract
The SOD3 variant, SOD3R213G, results from substitution of arginine to glycine at amino acid 213 (R213G) in its heparin binding domain (HBD) and is a common genetic variant, reported to be associated with ischemic heart disease. However, little is understood about the role of SOD3R213G in innate immune function, and how it leads to dysfunction of the cardiovascular system. We observed pathologic changes in SOD3R213G transgenic (Tg) mice, including cystic medial degeneration of the aorta, heart inflammation, and increased circulating and organ infiltrating neutrophils. Interestingly, SOD3R213G altered the profile of SOD3 interacting proteins in neutrophils in response to G-CSF. Unexpectedly, we found that G-CSF mediated tyrosine phosphatase, SH-PTP1 was down-regulated in the neutrophils of SOD3R213G overexpressing mice. These effects were recovered by reconstitution with Wt SOD3 expressing bone marrow cells. Overall, our study reveals that SOD3R213G plays a crucial role in the function of the cardiovascular system by controlling innate immune response and signaling. These results suggest that reconstitution with SOD3 expressing bone marrow cells may be a therapeutic strategy to treat SOD3R213G mediated diseases.
Introduction
Superoxide dismutase 3 (SOD3) is a member of the SOD family that scavenges superoxide and ROS produced by cells and tissues during inflammation [1]. Specifically, SOD3 is a glycoprotein with a heparin-binding domain (HBD) and is distributed throughout the extracellular matrix (ECM) of many tissues, including blood vessels and heart [2–6]. Binding of the HBD to heparan sulfate proteoglycans on cell surfaces and ECM is critical for the function of SOD3 [4], protecting these organs against oxidative stress [4, 7, 8]. We previously reported that SOD3 acts as a signal regulator by modulating innate and adaptive immune responses to ameliorate skin diseases and airway inflammation in mice [9, 10]. Considering that the ECM is essential for regulating intercellular communication [11], SOD3 may play a critical role for maintaining proper cellular function.
SOD3 variant R213G (SOD3R213G), the substitution of arginine to glycine at amino acid 213 in the HBD, is a common human gene variant [12, 13] and is known to be associated with many diseases, including ischemic heart disease [13] and vascular impairment [4]. Individuals who carry SOD3R213G exhibit increased plasma concentrations of SOD3 [14, 15], and have increased risk of ischemic heart disease [13]. Furthermore, SOD3R213G is associated with increased triglyceride levels and body weight [12]. Cohort studies showed that diabetic patients who carry SOD3R213G have higher mortality rates, including significantly higher death rates from ischemic heart disease and cerebrovascular disease than non-carriers [16]. In addition, SOD3 gene transfer reduces arterial pressure and improves vascular function (29). However, little is known about the role of SOD3R213G in innate immune function, which causes dysfunction of the cardiovascular system.
Neutrophils are released from the bone marrow (BM) and maintain homeostatic levels in the blood, in respond to infection. Granulocyte-colony stimulating factor (G-CSF) is a potent stimulus for releasing neutrophils from the BM during infection [17]. Binding of G-CSF to its receptor (G-CSFR) activates a number of signaling cascades, which controls granulopoiesis, proliferation, and trafficking of neutrophils [18, 19]. During activation, neutrophils clear pathogens by generating large amounts of ROS through a respiratory burst process [20]. However, the accumulated intracellular ROS damages healthy cells and organs [21]. In addition, activated neutrophils secrete extracellular remodeling substances, such as elastase, cathepsin G, and pro-inflammatory cytokines, which further accelerate tissue damage [22, 23]. Considering that SOD3 is located in the ECM, is highly expressed in the aorta and heart, and attenuates activation of neutrophils and inflammation [24], SOD3 may act as a front-line controller for immune response against microbial invasion.
In this study, we investigated the pathologic properties of SOD3R213G in the cardiovascular system using a transgenic mouse model. We report that SOD3R213G leads to cardiovascular dysfunction with failure maintaining immune response, increasing proliferation and trafficking of neutrophils in the cardiovascular system. Furthermore, SOD3R213G overexpressing neutrophils exhibit altered signaling, in response to G-CSF. However, these effects were recovered by transplantation with Wt SOD3 expressing BM cells. Taken together, these results suggest that arginine at amino acid 213 in the HBD of SOD3 is critical for the function of SOD3.
Materials and methods
Animals
All mice, including C57BL/6, SOD3 Tg, and SOD3R213G Tg mice, were used as previously described [10, 25] and cared for in semi-specific pathogen-free conditions. Animal experiments were performed in accordance with established institutional guidance that was approved by the Research Animal Care Committee of Catholic University (Seoul, Korea). The animals were sacrificed by cervical dislocation.
Quantitative real time-PCR
To perform qRT-PCR, the following mouse primers were used. Neutrophil secreting elastase, 5′-CTCTGGCTGCCATGCTACT, 3′-GTTCACACAGTGGGCTGCT; cathepsin G, 5′CGGCAGCAACT-GACTAAGC, 3′-CAAGCACTCAGCCCTTCTG; TERT, 5′-GTTCCTGTTCTGGCTGATG, 3′-CTTGTG-ACAGCTCCCGTAG; actin, 5’ AGCTGTGGACAAAGCCAACT, 3’-TTGGGCTCTCTCAGTTC-CCAC. Primers used for TNFα, IL-6, IL-1β, MCP-1, MIP1α, MIP1β, and CCR2 were described previously [10, 25]. All qRT-PCR data were normalized against mRNA levels of the actin gene.
Tissue histology and immunofluorescence staining
The tissues, including aorta and heart, were isolated and fixed in 4% paraformaldehyde in PBS and embedded in paraffin according to general histochemical procedure as previously described [9]. H&E staining, Masson’s staining, and Van Gieson’s staining were performed according the manufacturer’s instructions (Sigma, St Louis, MO). Inflammation, organ degeneration, and flattened and broken elastic fibers were assessed based on pathology criteria. To examine neutrophils infiltration, immunofluorescence staining was performed as previously described [9]. Fluorescence conjugated antibodies against CD11b (BioLegend, San Diego, CA), NIMP-R14 (Abcam, Cambridge, UK), and DAPI for nuclear staining (Vector Lab, Burlingame, CA) were diluted 1:100 and incubated for 1 hour at room temperature. The images were taken by confocal microscopy (Carl Zeiss, Thornwood, NY).
Blood differential staining
Blood was withdrawed from Wt or SOD3R213G mice. Fifty microliters of blood were subjected to cytospin at 45 rpm for 5 min, followed by Diff-Quick Staining (Sysmex Corporation). Inflammatory cells, including neutrophils, macrophages, or lymphocytes, were classified as previous described [10].
Cell surface and intracellular staining
APC-conjugated anti-mouse Ly-6G (Gr1, 1A8-Ly6g), PE-conjugated anti-mouse CD11b (M1/70), TNFα (MP6-XT22), and FITC–conjugated anti-mouse IL-6 (MP5-20F3) were purchased from eBioscience (San Diego, CA). PI and FITC-conjugated Annexin V were obtained from BioLegend (San Diego, CA). Cell surface, Gr1, CD11b, Annexin V, and PI were measured by flow cytometry (FACS Calibur, BD Bioscience, San Jose, CA). The content of Gr1+ BM mature neutrophils, and Gr1+ CD11b+ neutrophils of blood and spleen were assessed by representative flow cytometric analysis. The numbers represent the percentage of cells within the gates. At least 105 total cells were acquired by gating on size versus granularity, followed by exclusion of dead cells, and finally detection of markers described in plots. Cytokines TNFα and IL-6 in the spleen were assessed by flow cytometry after intracellular staining with permeabilizing reagent (BD Cytofix/Cytoperm). The data was analyzed with Cell Quest software (Becton Dickinson, Mountain View, CA) as previously described [9].
Proliferation and apoptosis of BM neutrophils
BM neutrophils were isolated and purified using antibody-magnetic bead depletion with the lineage cell depletion kit (Miltenyi Biotec, Bergisch Gladbach, Germany), and the proliferation was assessed as previously described [25]. The morphology of neutrophils was examined by light microscope. Apoptotic cells were assessed by staining with Annexin V and Propidium Iodide (PI). In some experiments, BM cells were used.
Neutrophil chemotaxis assay
Transwell plates of 3 μm pore size (Corning Costar, Cambridge, MA) were loaded with 600 μl of medium in the presence of fMLP (100 nM) in the lower chamber. Analyses were run in triplicate and migrated cells in the lower chamber were counted as previously described [25].
Immunoblot and immunoprecipitation
Antibodies for SH-PTP1 and β-actin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA), antibody for G-CSFR was obtained from Sigma (St. Louis, MO), and human SOD3 antibody was obtained from Abcam (Cambridge, MA). Immunoblot was performed as previously described [25]. Immunoprecipitation was performed using SOD3 antibody (Upstate Biotechnology, Lake Placid, NY) as previously described [10].
Measurement of ROS content and SOD activity
ROS generation of neutrophils was measured by staining with H2DCFH-DA, 2’, 7’- dichlorofluorescin-diacetate (5 μM), followed by FACS analysis as previously described [25]. Tissue or blood SOD activity was measured using a SOD assay kit (Dojindo lab, Kumamoto, Japan).
BM reconstitution
Seventeen week old SOD3R213G Tg mice were 900 rad γ-irradiated with Cs137 using Gamma cell 3000 Elan (MDS Nordion Co. Inc, Ottawa, Canada). BM stem cells were isolated from same age β-actin promoter driven SOD3 Tg mice as previously described [9]. Twelve hours later, the mice were intravenously injected with BM stem cells (2 ×106 cells). Mice were maintained on antibiotic water one day prior and one week after transplantation. Two months later, the mice were sacrificed for further analysis.
Mass spectrometry analysis
The neutrophils isolated from Wt or SOD3R213G Tg mice were treated with G-CSF (100 ng/mL). The cells were lysed for immunoprecipitation with an antibody against SOD3. The immunoprecipitation product was subjected to SDS-PAGE on 4–20% gradient gel, followed by Coomassie staining (S1 Fig). Bands around 35–47 and 75–95 kDa were removed from the gel for MS analysis as previously described [10]. The quantitative data was determined using Scaffold proteomics software (Proteome Software, Inc.). Identified proteins were obtained by 90% cut off range and unknown proteins were excluded.
Statistical analysis
The data was represented as the mean and standard error (SE) and analyzed by ANOVA at p<0.05 and Schiffe’s post hoc test, or t-test (p<0.001). Differences with p value below the stated thresholds were regarded as statistically significant.
Results
SOD3R213G Tg mice exhibit vascular pathologic changes including cystic medial degeneration and heart inflammation
In 17 week old SOD3R213G Tg mice, numerous pathological changes in the cardiovascular system were observed. As shown in Fig 1, cystic medial degeneration, including severe atrophic changes of aortic myocytes (Fig 1A, 4th panel), fibroblastic proliferation including increased interstitial collagen and separated myocytes (Fig 1B, 4th panel), hydropic degeneration (Fig 1B, 4th panel), and flattened and broken elastic fibers (Fig 1C, 4th panel) were observed in 17 week old SOD3R213G Tg mice, indicating that the mice were predisposed to aortic dissection or aneurism. In addition, heart inflammation was observed in 17 week old SOD3R213G Tg mice (Fig 1D, 4th panel). Furthermore, 17 week old SOD3R213G Tg mice had bigger hearts and thicker arterial vessels than Wt mice (Fig 1E and 1F). However, these phenotypes were not observed in 5 week old SOD3R213G Tg mice or Wt mice, indicating that the pathology is a progressive development after environmental exposure (Fig 1A–1D, right panel). These histological analyses were further confirmed by assessing the expression of corresponding genes in the aorta: fibrosis and elastin break related genes, fibrullin-1 and MMP9 (Fig 1G and 1H); molecules for recruiting pro-inflammatory substances, ICAM and VCAM (Fig 1I and 1J); apoptosis related genes, Bax (Fig 1K), p53 (Fig 1L), and Cyclin D1 (Fig 1M). Therefore, these results suggest that 17 week old SOD3R213G Tg mice exhibit cardiovascular pathologic changes.
Neutrophils highly infiltrate in the aorta and heart of SOD3R213G Tg mice
As shown in the result of immunofluorescence staining in Fig 2A, increased infiltration of CD11b positive cells and NIMP-14 positive cells was observed the aorta and heart of 17 week old SOD3R213G Tg mice, indicating that SOD3R213G Tg mice have increased innate immune response with dominant infiltration of neutrophils. A similar pattern was observed in periphery (Fig 2B). Consistently, the expression of the chemo-attractants MCP-1, MIP1α, and MIP1β was up-regulated in the aorta and heart of the SOD3R213G Tg mice (Fig 2C–2E). Correspondingly, the expression of inflammatory genes TNFα, IL-1β, and IL-6 was also up-regulated (Fig 2F–2H). In addition, the expression of elastase and the aging marker TERT was upregulated in the aorta and heart of SOD3R213G Tg mice (Fig 2I and 2J), implying that 17 week old SOD3R213G Tg mice exhibit a premature aging phenotype.
Premature aging SOD3R213G Tg mice develop neutrophilia
Consistently, increased numbers of Gr1+ CD11b+ neutrophils were observed in the spleen of the SOD3R213G mice (Fig 3A). Correspondingly, the pro-inflammatory cytokines TNFα (Fig 3B) and IL-6 (Fig 3C) levels were increased. A similar pattern was observed in the periphery of SOD3R213G mice (Fig 3D), but BM neutrophil content was not affected (Fig 3E). Thus, these results indicate that SOD3R213G Tg mice may be sensitized by infection and have the potential for neutrophil-mediated inflammation. This implies that SOD3 may have a role in protecting against infection, and arginine at amino acid 213 in the HBD plays a key role in this function.
SOD3R213G alters SOD3 mediated signaling, which changes the function of neutrophils
Based on these results, we further investigated the role of SOD3R213G at the molecular level. We hypothesized that SOD3R213G may alter SOD3 mediated signaling pathways in neutrophils by changing SOD3 interacting proteins, which may, in turn, change their characteristics and functions. To test this possibility, neutrophils were isolated from 17 week old SOD3R213G Tg or Wt mice and treated with G-CSF. The cells were lysed to perform immunoprecipitation using anti-SOD3 and bands were isolated for mass spectrometric analysis (S1 Fig). As we expected, SOD3R213G expressing neutrophils had an altered profile of SOD3 interacting proteins in response to G-CSF treatment (S1 Table). Specifically, SOD3 interacted with membrane receptors and transporters, including T-complex protein, Arhgap21 protein, and synemin isoform HF (S1 Table), but these interactions were amplified in SOD3R213G expressing neutrophils. In addition, SOD3R213G interacted with the Usherin precursor, sodium bicarbonate cotransporter, docking protein 1, IRK2 channel protein, serine/threonine protein kinases TAO2 isoform 1, and G protein-coupled receptor 110, which did not interact with SOD3 (S1 Table). Thus, we further clarified these results at the cellular level.
G-CSF and G-CSFR are critical in response of neutrophils to bacterial infection, controlling granulopoiesis and trafficking [26, 27]. Interestingly, G-CSFR was over-expressed in neutrophils isolated from 17 week old SOD3R213G Tg mice compared to those of Wt mice (Fig 4A, middle panel). A consistent pattern was observed in the protein level (Fig 4B. middle panel). Surprisingly, G-CSF mediated Src homology protein tyrosine phosphatase, SH-PTP1, was down-regulated in SOD3R213G expressing neutrophils (Fig 4C, top panel). Subsequently, the neutrophils showed increased proliferation (Fig 4D), apoptosis (Fig 4E), and expression of chemokine receptor CCR2 (Fig 4F), upregulating their trafficking. However, interestingly, SOD3R213G did not affect granulopoiesis (Fig 4G) or maturation of neutrophils (Fig 4H). Taken together, these results suggest that SOD3R213G expressing neutrophils have altered SOD3 mediated signaling in response to environmental pathogens, promoting proliferation and trafficking of neutrophils. Therefore, these results imply that SOD3 acts as a signaling molecule to control innate immune response, and arginine at amino acid 213 of HBD is critical for this function.
Aberrant phenotype of SOD3R213G Tg mice is recovered by reconstitution with SOD3 expressing BM cells
A study showed that SOD3 gene transfer to damaged tissue results in increased healing [28]. In addition, treatment of cardiovascular tissues with SOD3 reduces the extent of the damage, increases the healing process, and improves cardiac function [28]. Based on that information and to confirm the pathologic properties of SOD3R213G and its molecular mechanisms, BM stem cells were isolated from 17 week old SOD3 Tg mice and transplanted into lethally irradiated same background and same age SOD3R213G Tg recipient mice (Fig 5A). Two months later, SOD3R213G expression was assessed in transplanted mice. As shown in Fig 5B and Fig 5C, SOD3R213G expression was drastically decreased in BM transplanted SOD3R213G mice. Using FACS analysis, we found that the transplanted mice have a similar level of BM cells to SOD3R213G mice (Fig 5D), indicating that transplanted BM cells restored normal granulopoiesis in γ-irradiated SOD3R213G Tg mice. The profile of blood immune cells of transplanted mice was similar to Wt (Fig 5E). As we expected, the numbers of neutrophils in the periphery (Fig 5F) and spleen (Fig 5G) were dramatically reduced in the transplanted mice compared to SOD3R213G Tg mice. Consistently, activated blast-like form and highly aggregated neutrophils in SOD3R213G reverted to the Wt phenotype (Fig 5H), and increased ROS level in neutrophils of SOD3R213G Tg mice returned to the Wt levels (Fig 5I). Subsequently, the expression level of pro-inflammatory and tissue damaging molecules TNFα (Fig 5J), elastase (Fig 5K), and cathepsin G (Fig 5L) in neutrophils of SOD3R213G Tg mice, was drastically reduced by transplantation.
Altered signaling and aberrant function of the neutrophils are recovered by reconstitution with SOD3 expressing BM cells, which ultimately recover the cardiovascular system
As we expected, up-regulated G-CSFR expression in the neutrophils of SOD3R213G Tg mice was drastically reduced by transplantation (Fig 6A and 6B, top panel). In addition, down-regulation of G-CSF mediated tyrosine phosphatase SH-PTP1 in neutrophils of SOD3R213G Tg mice was recovered by reconstitution with SOD3 expressing BM cells (Fig 6C, top panel). Consistently, aberrant neutrophils function, including proliferation (Fig 6D), apoptosis (Fig 6E), CCR2 expression (Fig 6F), and chemotaxis (Fig 6G), returned to Wt level by transplantation.
Finally, vascular pathologic changes including aortic myocyte degeneration, cystic medial degeneration, and heart inflammation in SOD3R213G Tg mice were recovered by transplantation (Fig 6H–6K). Correspondingly, increased levels of the pro-inflammatory cytokine IL-6 (Fig 6L) and elastase (Fig 6M) in the aorta and heart were also significantly reduced by transplantation. Moreover, SOD3 in the blood of SOD3R213G Tg mice was reduced to Wt level by the transplantation (Fig 6N, top panel). Taken together, these results confirmed that the pathologic properties of SOD3R213G and its molecular mechanism are recovered by transplantation of SOD3 expressing BM cells.
Discussion
In the present study, we demonstrated that overexpression of SOD3R213G causes aortic degeneration and heart inflammation, which eventually leads to loss in cardiovascular function. One of the mechanisms we proposed is that overexpression of SOD3R213G causes increased proliferation and trafficking of neutrophils by altering protein interactions with SODR213G and down-regulating SH-PTP1 signaling (Fig 7). These effects were recovered by bone marrow transplantation (BMT) with Wt SOD3.
A key feature of SOD3 protein structure is the carboxy-terminus containing 6 positively charged amino acids, which is essential for anchoring to the negatively charged ECM [29]. SOD3R213G disrupts the positive charge of SOD3 and reduces the affinity for the ECM, leading to its redistribution to the extracellular fluid space, such as plasma and epithelial lining fluid [29]. In agreement with our finding, it was reported that SOD3 reduces the superoxide level and improves aortic relaxation in response to LPS treatment, but SOD3R213G fails to protect against endothelial dysfunction [30]. As a possible mechanism, it has been reported that SOD3R213G alters the affinity of the HBD for heparin via conformational change [31]. A study showed that SOD3R213G binds to bovine aortic endothelial cells 50 fold less than SOD3 [32]. In addition, SOD3 is released into the blood in humans who carry the SOD3R213G variant [14, 32, 33], which is consistent with our result. However, it has also been reported that SOD3R213G does not change SOD3 functions, but only in its distribution [29], and SOD3R213G attenuates the risk of exacerbation of COPD [29] and protects against allergic airway inflammation [29]. This discrepancy may be due to different organs, different morbidity, and redistribution of SOD3 into extracellular fluids which play a critical role in the function of the lung. Thus, it seems that proper affinity of SOD3 to the ECM is essential for the prevention of inflammatory and degenerative diseases in the cardiovascular system.
Unlike Wt SOD3, we observed that SOD3R213G Tg mice promotes innate immune responses. Specifically, higher numbers of neutrophils infiltrated to the organs of SOD3R213G Tg mice over time, which promotes ROS generation and secretion of pro-inflammatory and tissue damaging molecules. Consistently, a study has shown that SOD3 inhibits innate immune response by decreasing colocalizing of neutrophils with bacteria and increasing neutrophil apoptosis, reducing neutrophil-specific TNFα and peroxynitrite production [34]. Considering that neutrophils are involved in many parts of cardiovascular pathophysiology [35] and elevated blood neutrophils are a predictor of cardiovascular death in patients with coronary artery disease [35], it seems that the fundamental function of SOD3 under physiological conditions is controlling immune response against microbial invasion. However, the present study showed that SOD3R213G Tg mice does not affect neutrophil development. Instead, it affects proliferation and trafficking of neutrophils. A supportive study suggested that SOD3 mRNA is absent throughout neutrophil maturation, but it is synthesized in other cells and subsequently endocytosed by the neutrophils [36]. Thus, further investigation of role of SOD3 in immune cells is warranted.
In this study, all mice were maintained in a semi-specific pathogen-free (SPF) condition. However, it is likely that SOD3R213G Tg mice still experienced immune sensitizing in that environment, which initiates up-regulation of G-CSF mediated signaling and alters interacting proteins. As a consequence, SOD3R213G expressing neutrophils changed their functions, leading to a progressive deterioration of the aorta and heart. In addition, higher neutrophils levels in the periphery resulted in increased blood levels of SOD3. Supporting our findings, G-CSF has been shown to promote mobilization of neutrophils from the BM to the blood [37]. Moreover, many signaling molecules, including JAK, Src family tyrosine kinases, PI3/Akt, and Ras/MAPK pathways participate in the G-CSFR mediated signal transduction cascade [38, 39]. Furthermore, IL-1β-Myd 88 axis and NADPH oxidase-mediated ROS signaling regulate neutrophil migration [40]. Thus, further investigation is warranted to clarify the immune cell profile of SOD3R213G Tg mice and demonstrate how SOD3R213G altered signaling pathways against pathogens.
However, while Tg mice which express SOD3 lacking HBD have a similar phenotype to SOD3 Tg mice, a functional difference of SOD3 was observed in SOD3R213G Tg mice [25]. Although SOD3 Knock out (Ko) mice were susceptible to inflammation, they do not present similar phenotypes to SOD3R213G Tg mice, which may be due to the functional redundancy of SOD3. In other words, other SODs, such as SOD1 or SOD2, may compensate to promote protective effects in both SOD3 lacking HBD Tg and SOD3 Ko mice. Indeed, SOD1 and SOD3 are both belong to Cu, Zn- SOD and have 50% homologues each other [41]. In addition, study showed that while SOD2 Ko (SOD2-/-) mice are lethal within 3–4 week after birth, SOD1 Ko or SOD3 Ko mice are not lethal [42]. This suggests that compensatory mechanism is operating at least for SOD1 and SOD3. Furthermore, we observed the unique phenotype and altered the neutrophils function in SODR213G overexpressing mice whose generated by universal promoter, instead of generating target specific knock-in mice. Thus, we may further clarify if there is discrepancy between these mice. Taken together, these findings suggest that SOD3 may play a protective role by controlling immune response, at least in part, through orchestration of proper signaling in response to environmental pathogens. In that sense, arginine 213 in the HBD of SOD3 is essential for the signaling function of SOD3.
We demonstrated that SOD3R213G mediated aortic degeneration can be recovered by reconstitution with SOD3 expressing BM cells. A supportive study reported that SOD3 gene transfer using an adenoviral vector reduces the extent of cardiovascular damage, improves cardiac function, reducing remodeling of vasculature, attenuating apoptosis, inhibiting inflammatory and smooth muscle cell migration, and increasing cell proliferation and endothelial cell layer recovery [28]. Regarding this, it has been shown that although the remaining myocytes are unable to repair necrotic tissue, the injured organ is sensed by distant stem cells, which migrate to the site of damage and undergo alternative stem cell differentiation [43, 44]. Supportive studies showed that injection of Lin-c-kitpos BM cells in infarcted mice regenerate the myocardium [45]. However, gene therapy has limitations as an approach due to its safety and delivery issues [46], which led us to apply bone marrow transplantation.
In summary, the present study shows that SOD3R213G Tg mice has pathogenic characteristics in the cardiovascular system by increasing sensing infection, increasing proliferation and trafficking of neutrophils and altering their signaling pathways. Therefore, arginine 213 of HBD of SOD3 is critical for the function of SOD3 in the cardiovascular system, and SOD3 expressing BMT may be a potential therapeutic strategy.
Supporting information
Acknowledgments
We thank Mr. Byung-Hun Lee and Mr. Hee- Jong Ahn (Integrative Research Support Center, the Catholic University of Korea, Seoul) for their technical supports, including γ-radiation.
Data Availability
All relevant data are within the paper and supporting information files.
Funding Statement
The research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government, MSIP(NRF-2016M3A9B6903020).
References
- 1.Marklund SL, Holme E, Hellner L. Superoxide dismutase in extracellular fluids. Clin Chim Acta. 1982;126(1):41–51. Epub 1982/11/24. 10.1016/0009-8981(82)90360-6 . [DOI] [PubMed] [Google Scholar]
- 2.Folz RJ, Crapo JD. Extracellular superoxide dismutase (SOD3): tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics. 1994;22(1):162–71. Epub 1994/07/01. 10.1006/geno.1994.1357 . [DOI] [PubMed] [Google Scholar]
- 3.Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15(11):2032–6. Epub 1995/11/01. 10.1161/01.atv.15.11.2032 . [DOI] [PubMed] [Google Scholar]
- 4.Chu Y, Alwahdani A, Iida S, Lund DD, Faraci FM, Heistad DD. Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation. 2005;112(7):1047–53. Epub 2005/08/10. 10.1161/CIRCULATIONAHA.104.531251 . [DOI] [PubMed] [Google Scholar]
- 5.Oury TD, Chang LY, Marklund SL, Day BJ, Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest. 1994;70(6):889–98. Epub 1994/06/01. . [PubMed] [Google Scholar]
- 6.Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med. 1996;20(7):957–65. Epub 1996/01/01. 10.1016/0891-5849(95)02222-8 . [DOI] [PubMed] [Google Scholar]
- 7.Bowler RP, Arcaroli J, Crapo JD, Ross A, Slot JW, Abraham E. Extracellular superoxide dismutase attenuates lung injury after hemorrhage. Am J Respir Crit Care Med. 2001;164(2):290–4. Epub 2001/07/21. 10.1164/ajrccm.164.2.2011054 . [DOI] [PubMed] [Google Scholar]
- 8.Yao H, Arunachalam G, Hwang JW, Chung S, Sundar IK, Kinnula VL, et al. Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc Natl Acad Sci U S A. 2010;107(35):15571–6. Epub 2010/08/18. 10.1073/pnas.1007625107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kwon MJ, Han J, Kim BH, Lee YS, Kim TY. Superoxide dismutase 3 suppresses hyaluronic acid fragments mediated skin inflammation by inhibition of toll-like receptor 4 signaling pathway: superoxide dismutase 3 inhibits reactive oxygen species-induced trafficking of toll-like receptor 4 to lipid rafts. Antioxid Redox Signal. 2012;16(4):297–313. Epub 2011/10/01. 10.1089/ars.2011.4066 . [DOI] [PubMed] [Google Scholar]
- 10.Kwon MJ, Jeon YJ, Lee KY, Kim TY. Superoxide dismutase 3 controls adaptive immune responses and contributes to the inhibition of ovalbumin-induced allergic airway inflammation in mice. Antioxid Redox Signal. 2012;17(10):1376–92. Epub 2012/05/16. 10.1089/ars.2012.4572 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196(4):395–406. Epub 2012/02/22. 10.1083/jcb.201102147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Marklund SL, Nilsson P, Israelsson K, Schampi I, Peltonen M, Asplund K. Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med. 1997;242(1):5–14. Epub 1997/07/01. 10.1046/j.1365-2796.1997.00160.x . [DOI] [PubMed] [Google Scholar]
- 13.Juul K, Tybjaerg-Hansen A, Marklund S, Heegaard NH, Steffensen R, Sillesen H, et al. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study. Circulation. 2004;109(1):59–65. Epub 2003/12/10. 10.1161/01.CIR.0000105720.28086.6C . [DOI] [PubMed] [Google Scholar]
- 14.Sandstrom J, Nilsson P, Karlsson K, Marklund SL. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem. 1994;269(29):19163–6. Epub 1994/07/22. . [PubMed] [Google Scholar]
- 15.Adachi T, Ohta H, Yamada H, Futenma A, Kato K, Hirano K. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta. 1992;212(3):89–102. Epub 1992/11/30. 10.1016/0009-8981(92)90176-q . [DOI] [PubMed] [Google Scholar]
- 16.Kobylecki CJ, Afzal S, Nordestgaard BG. Genetically Low Antioxidant Protection and Risk of Cardiovascular Disease and Heart Failure in Diabetic Subjects. EBioMedicine. 2015;2(12):2010–5. Epub 2016/02/05. 10.1016/j.ebiom.2015.11.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, et al. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990;76(10):1962–4. Epub 1990/11/15. . [PubMed] [Google Scholar]
- 18.Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 1996;88(3):761–77. Epub 1996/08/01. . [PubMed] [Google Scholar]
- 19.Abe T, Satoh K, Motomiya M. [Extracellular matrix, adhesion molecules and cytoskeleton of the lung]. Kokyu To Junkan. 1993;41(4):308–18. Epub 1993/04/01. . [PubMed] [Google Scholar]
- 20.Babior BM. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med. 1978;298(12):659–68. Epub 1978/03/23. 10.1056/NEJM197803232981205 . [DOI] [PubMed] [Google Scholar]
- 21.Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 1993;262(5137):1274–7. Epub 1993/11/19. 10.1126/science.8235659 . [DOI] [PubMed] [Google Scholar]
- 22.Belaaouaj A, Kim KS, Shapiro SD. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science. 2000;289(5482):1185–8. Epub 2000/08/19. 10.1126/science.289.5482.1185 . [DOI] [PubMed] [Google Scholar]
- 23.Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3):173–82. Epub 2006/02/25. 10.1038/nri1785 . [DOI] [PubMed] [Google Scholar]
- 24.Bowler RP, Nicks M, Tran K, Tanner G, Chang LY, Young SK, et al. Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation. Am J Respir Cell Mol Biol. 2004;31(4):432–9. Epub 2004/07/17. 10.1165/rcmb.2004-0057OC . [DOI] [PubMed] [Google Scholar]
- 25.Kwon MJ, Lee KY, Lee HW, Kim JH, Kim TY. SOD3 Variant, R213G, Altered SOD3 Function, Leading to ROS-Mediated Inflammation and Damage in Multiple Organs of Premature Aging Mice. Antioxid Redox Signal. 2015;23(12):985–99. Epub 2015/05/01. 10.1089/ars.2014.6035 . [DOI] [PubMed] [Google Scholar]
- 26.Liu F, Wu HY, Wesselschmidt R, Kornaga T, Link DC. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity. 1996;5(5):491–501. Epub 1996/11/01. 10.1016/s1074-7613(00)80504-x . [DOI] [PubMed] [Google Scholar]
- 27.Lieschke GJ, Stanley E, Grail D, Hodgson G, Sinickas V, Gall JA, et al. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood. 1994;84(1):27–35. Epub 1994/07/01. . [PubMed] [Google Scholar]
- 28.Laukkanen MO. Extracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor? Oxid Med Cell Longev. 2016;2016:3612589 Epub 2016/06/14. 10.1155/2016/3612589 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Gaurav R, Varasteh JT, Weaver MR, Jacobson SR, Hernandez-Lagunas L, Liu Q, et al. The R213G polymorphism in SOD3 protects against allergic airway inflammation. JCI Insight. 2017;2(17). Epub 2017/09/08. 10.1172/jci.insight.95072 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lund DD, Chu Y, Brooks RM, Faraci FM, Heistad DD. Effects of a common human gene variant of extracellular superoxide dismutase on endothelial function after endotoxin in mice. J Physiol. 2007;584(Pt 2):583–90. Epub 2007/08/25. 10.1113/jphysiol.2007.140830 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Petersen SV, Olsen DA, Kenney JM, Oury TD, Valnickova Z, Thogersen IB, et al. The high concentration of Arg213—>Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities. Biochem J. 2005;385(Pt 2):427–32. Epub 2004/09/15. 10.1042/BJ20041218 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Adachi T, Yamada H, Yamada Y, Morihara N, Yamazaki N, Murakami T, et al. Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem J. 1996;313 (Pt 1):235–9. Epub 1996/01/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Folz RJ, Peno-Green L, Crapo JD. Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum Mol Genet. 1994;3(12):2251–4. Epub 1994/12/01. 10.1093/hmg/3.12.2251 . [DOI] [PubMed] [Google Scholar]
- 34.Break TJ, Jun S, Indramohan M, Carr KD, Sieve AN, Dory L, et al. Extracellular superoxide dismutase inhibits innate immune responses and clearance of an intracellular bacterial infection. J Immunol. 2012;188(7):3342–50. Epub 2012/03/07. 10.4049/jimmunol.1102341 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hoyer FF, Nahrendorf M. Neutrophil contributions to ischaemic heart disease. Eur Heart J. 2017;38(7):465–72. Epub 2017/04/01. 10.1093/eurheartj/ehx017 . [DOI] [PubMed] [Google Scholar]
- 36.Iversen MB, Gottfredsen RH, Larsen UG, Enghild JJ, Praetorius J, Borregaard N, et al. Extracellular superoxide dismutase is present in secretory vesicles of human neutrophils and released upon stimulation. Free Radic Biol Med. 2016;97:478–88. Epub 2016/07/11. 10.1016/j.freeradbiomed.2016.07.004 . [DOI] [PubMed] [Google Scholar]
- 37.Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity. 2002;17(4):413–23. Epub 2002/10/22. 10.1016/s1074-7613(02)00424-7 . [DOI] [PubMed] [Google Scholar]
- 38.Dong F, Larner AC. Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood. 2000;95(5):1656–62. Epub 2000/02/26. . [PubMed] [Google Scholar]
- 39.Rausch O, Marshall CJ. Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol Cell Biol. 1997;17(3):1170–9. Epub 1997/03/01. 10.1128/mcb.17.3.1170 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Yan B, Han P, Pan L, Lu W, Xiong J, Zhang M, et al. IL-1beta and reactive oxygen species differentially regulate neutrophil directional migration and Basal random motility in a zebrafish injury-induced inflammation model. J Immunol. 2014;192(12):5998–6008. Epub 2014/05/20. 10.4049/jimmunol.1301645 . [DOI] [PubMed] [Google Scholar]
- 41.Kwon MJ, Kim B, Lee YS, Kim TY. Role of superoxide dismutase 3 in skin inflammation. J Dermatol Sci. 2012;67(2):81–7. Epub 2012/07/06. 10.1016/j.jdermsci.2012.06.003 . [DOI] [PubMed] [Google Scholar]
- 42.Wang Y, Branicky R, Noe A, Hekimi S. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol. 2018;217(6):1915–28. Epub 2018/04/20. 10.1083/jcb.201708007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279(5356):1528–30. Epub 1998/03/21. 10.1126/science.279.5356.1528 . [DOI] [PubMed] [Google Scholar]
- 44.Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A. 1999;96(25):14482–6. Epub 1999/12/10. 10.1073/pnas.96.25.14482 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701–5. Epub 2001/04/05. 10.1038/35070587 . [DOI] [PubMed] [Google Scholar]
- 46.Maeder ML, Gersbach CA. Genome-editing Technologies for Gene and Cell Therapy. Mol Ther. 2016;24(3):430–46. Epub 2016/01/13. 10.1038/mt.2016.10 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and supporting information files.